Press Releases

Year

Mar 2025

LifeVantage Announces Launch of LV360 and Evolve Compensation Plan in Philippines, Taiwan, Hong Kong, and Singapore Markets

Phase 3 of the Evolve Compensation Plan launches on March 1, 2025, furthering opportunities for success SALT LAKE CITY , March 03, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation ® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at

PDF Version

Feb 2025

LifeVantage Declares Quarterly Dividend

SALT LAKE CITY , Feb. 05, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company’s Board of Directors has approved a quarterly cash

PDF Version

Feb 2025

LifeVantage Announces Financial Results for the Second Quarter of Fiscal 2025

SALT LAKE CITY , Feb. 05, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its second fiscal quarter ended December 31, 2024

PDF Version

Feb 2025

LifeVantage Announces Completion of International In Vitro Study on the MB System™

Recent Study Testing International Formulation Shows Significant Increase in GLP-1 Hormone SALT LAKE CITY , Feb. 04, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation ® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular

PDF Version

Jan 2025

LifeVantage to Announce Second Quarter Fiscal Year 2025 Results on February 5, 2025

SALT LAKE CITY , Jan. 22, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its second quarter ended

PDF Version

Jan 2025

TrueScience® Activated Skincare Collection Recognized for Cutting-Edge Innovation, Clean Beauty Standards, and Proven Anti-Aging Results*

TrueScience® Wins Silver for Most Innovative Product Line at Best in Biz Awards 2024 SALT LAKE CITY , Jan. 21, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation ® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level,

PDF Version

Jan 2025

LifeVantage Welcomes Todd Thompson as Chief Information and Innovation Officer

Technology leader brings decades of expertise in innovation, scalability and customer-focused solutions to accelerate LifeVantage’s growth and digital transformation SALT LAKE CITY , Jan. 16, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company

PDF Version

Jan 2025

LifeVantage Launches 2025 Vision with “Drive ERA” Theme and International Expansion Plans for Evolve Compensation Plan and the MindBody GLP-1 System™

New Innovations and Incentives Empower Consultants to Accelerate Business Growth in 2025 SALT LAKE CITY , Jan. 13, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular

PDF Version

Jan 2025

LifeVantage Study Confirms Breakthrough Synergistic Effects of Healthy Weight Stack*

Protandim® Nrf2 Synergizer® and MindBody GLP-1 System™ Amplify Benefits While Activating New Results SALT LAKE CITY , Jan. 13, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leader in cellular activation of optimal health processes, today announced the results of a

PDF Version

Jan 2025

LifeVantage Announces Preliminary Second Quarter Revenue Results and Raises Fiscal 2025 Revenue Guidance

SALT LAKE CITY , Jan. 08, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced preliminary revenue results for the second quarter ended December 31,

PDF Version

Pagination

First page
Previous page
Page 1
Page 2
Page 3
Current page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page